Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Filings indexed 1,096 across all filing types
Latest filing 2021-02-09 Director's Dealing
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-02-09 English
PRIMARY DOCUMENT
Director's Dealing
2021-02-08 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the departure of a director/officer (the CFO and Secretary) and the terms of his separation agreement. There are no financial statements or earnings data presented, nor is this an annual or quarterly report. The key section is Item 5.02, which relates to changes in directors or officers. Therefore, this filing is best classified as Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a certification but a substantive report on management changes.
2021-02-02 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-29 English
PRIMARY DOCUMENT
Director's Dealing
2021-01-21 English
PRIMARY DOCUMENT
Director's Dealing
2021-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.